Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation

International Journal of Hematology

Volumn 99, Issue 1, 2014, Pages 95-99

  Yoshida, Hitoshi ^a   Ohshima, Kenji ^a   Toda, Jun ^a   Kusakabe, Shinsuke ^a   Masaie, Hiroaki ^a   Yagi, Toshinari ^a   Ishikawa, Jun ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Allogeneic hematopoietic cell transplantation; Mefloquine; Mirtazapine; Progressive multifocal leukoencephalopathy

Indexed keywords

ADULT; ANTIVIRAL AGENTS; BRAIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MEFLOQUINE; MIANSERIN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84898880488     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-013-1471-0     Document Type: Article

References (18)

1. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol. 2010;9(4):425-37.
2. Mollory ES, Calabrese LH. Progressive multifocal leukoencephalopathy. A national estimate of frequency in systemic lupus erythematosus and other rheumatic disease. Arthr Rheum. 2009;60(12):3761-5.
3. Mateen FJ, Muralidharan R, Carone M, van de Beek D, Harrison DM, Aksamit AJ, et al. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol. 2011;70(2):305-22.
4. Kharfan-Dabaja MA, Ayala E, Greene J, Rojiani A, Murtagh FR, Anasetti C. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant. 2007;39(2):101-7. (Pubitemid 46085228)
5. Engsig FN, Hansen AB, Omland LH, Kronborg G, Gerstoft J, Laursen AL, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis. 2009;199(1):77-83.
6. Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother. 2009;53(5):1840-9.
7. Gofton TE, Al-Khotani A, O'Farrell B, Ang LC, McLachlan RS. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2009;82(4):452-5.
8. Naito K, Ueno H, Seike M, Kanemitsu M, Ohshita T, Nakamura T, et al. Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: a serial multimodal MRI study. Intern Med. 2012;51(2):205-9.
9. Beppu M, Kawamoto M, Nukuzuma S, Kohara N. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med. 2012;51(10):1245-7.
10. Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;18(306):1380-3. (Pubitemid 39532516)
11. Verma S, Cikurel K, Koralnik IJ, Morgello S, Cunningham-Rundles C, Weinstein ZR, et al. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis. 2007;196(5):709-11. (Pubitemid 47293853)
12. Lanzafame M, Ferrari S, Lattuada E, Corsini F, Deganello R, Vento S, et al. Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy. Infez Med. 2009;17(1):35-7.
13. Chen DB, Song QJ, Chen YX, Chen YH, Shen DH. Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2013;97(1):117-24.
14. Marzocchetti A, Tompkins T, Clifford DB, Gandhi RT, Kesari S, Berger JR, Simpson DM, Prosperi M, De Luca A, Koralnik IJ. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009;73(19):1551-8.
15. Clifford DB, De Luca A, Simpson DM, Arent G, Giovannoti G, Nath A. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lesson from 28 cases. Lancet Neurol. 2010;9(4):438-46.
16. Tan K, Roda R, Ostrow L, McArther J, Nath A. PML-IRIS in patients with HIV infection. Clinical manifestations and steroids. Neurology. 2009;72(17):1458-64.
17. Bladuzzi A, Lucchini G, Hirsch HH, Basso S, Cioni M, Rovelli A, et al. Polyoma virus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient. Bone Marrow Transplant. 2011;46(7):987-92.
18. Kishida S, Tanaka K. Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med. 2010;49(22):2509-11.